Loading…

Settings and effectiveness of the revised probe compared to the original probe for micropulse transscleral cyclophotocoagulation

Purpose The goal of this study was to compare the settings and effectiveness of the original P3 and revised P3 probes for micropulse transscleral cyclophotocoagulation. Methods This retrospective cross sectional study includes a total of 56 patients with glaucoma who received micropulse transscleral...

Full description

Saved in:
Bibliographic Details
Published in:Lasers in medical science 2024-05, Vol.39 (1), p.136-136, Article 136
Main Authors: Hadjokas, Nicholas, Dosakayala, Neelima, Alpert, Samuel, Ganapathy, Preethi, Fechtner, Robert
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c256t-bf41f58fb64b11bccf06dd882fb56c4740c8b9337016bd1c9369fc793889175e3
container_end_page 136
container_issue 1
container_start_page 136
container_title Lasers in medical science
container_volume 39
creator Hadjokas, Nicholas
Dosakayala, Neelima
Alpert, Samuel
Ganapathy, Preethi
Fechtner, Robert
description Purpose The goal of this study was to compare the settings and effectiveness of the original P3 and revised P3 probes for micropulse transscleral cyclophotocoagulation. Methods This retrospective cross sectional study includes a total of 56 patients with glaucoma who received micropulse transscleral cyclophotocoagulation. 32 patients received treatment with the original P3 probe and 24 received treatment with the revised P3 probe. Success was defined as a 20% reduction in intraocular pressure. Laser settings, pre-op and post-op intraocular pressures, and pre-op and post-op medications were assessed. Results A 20% IOP reduction was achieved in 50% of patients in the original probe vs. 58.3% in the revised probe at one month ( P  = 0.536) and 71.9% vs. 50% at three months ( P  = 0.094), respectively. The revised P3 probe used higher values of power (2500 mW vs. 2023 mW, P  
doi_str_mv 10.1007/s10103-024-04086-z
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3060372680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3060372680</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-bf41f58fb64b11bccf06dd882fb56c4740c8b9337016bd1c9369fc793889175e3</originalsourceid><addsrcrecordid>eNp9kctu1jAQhS0Eohd4ARbIEhs2gXGcOM4SVQUqVeoCKnVn2c74r6skDrZTqV3x6LjNz0UsuhqPzjdnPDqEvGHwgQF0HxMDBryCuqmgASmq-2fkkDW8rQQ0V8__eR-Qo5RuAFgnGH9JDrjs-rau5SH5-Q1z9vMuUT0PFJ1Dm_0tzpgSDY7ma6QRb33CgS4xGKQ2TIuOpc3hUQ3R7_ysx73sQqSTtzEs65iQ5qjnlOyIsRD2zo5huQ452KB366izD_Mr8sLpgr7e12Ny-fn0-8nX6vziy9nJp_PK1q3IlXENc610RjSGMWOtAzEMUtbOtMI2XQNWmp7zDpgwA7M9F72zXc-l7FnXIj8m7zff8s8fK6asJp8sjqOeMaxJcRDAu1pIKOi7_9CbsMZy40ZBWQYPVL1R5diUIjq1RD_peKcYqId81JaPKvmox3zUfRl6u7dezYTDn5HfgRSAb0Aq0rzD-Hf3E7a_ANfJnmk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3060074000</pqid></control><display><type>article</type><title>Settings and effectiveness of the revised probe compared to the original probe for micropulse transscleral cyclophotocoagulation</title><source>Springer Link</source><creator>Hadjokas, Nicholas ; Dosakayala, Neelima ; Alpert, Samuel ; Ganapathy, Preethi ; Fechtner, Robert</creator><creatorcontrib>Hadjokas, Nicholas ; Dosakayala, Neelima ; Alpert, Samuel ; Ganapathy, Preethi ; Fechtner, Robert</creatorcontrib><description>Purpose The goal of this study was to compare the settings and effectiveness of the original P3 and revised P3 probes for micropulse transscleral cyclophotocoagulation. Methods This retrospective cross sectional study includes a total of 56 patients with glaucoma who received micropulse transscleral cyclophotocoagulation. 32 patients received treatment with the original P3 probe and 24 received treatment with the revised P3 probe. Success was defined as a 20% reduction in intraocular pressure. Laser settings, pre-op and post-op intraocular pressures, and pre-op and post-op medications were assessed. Results A 20% IOP reduction was achieved in 50% of patients in the original probe vs. 58.3% in the revised probe at one month ( P  = 0.536) and 71.9% vs. 50% at three months ( P  = 0.094), respectively. The revised P3 probe used higher values of power (2500 mW vs. 2023 mW, P  &lt; 0.0001), total duration (217 s vs. 179 s, P  &lt; 0.0001), and energy (170 J vs. 113 J, P  &lt; 0.001). There was a significant decrease in IOP lowering meds with the original probe at one month (-0.9 +/- 1.5 vs. -0.0 +/- 0.7, P  = 0.010), but this was not seen at three months. Conclusions There is no significant difference in IOP lowering effect between probes despite the revised probe using higher total energy. The original probe may be associated with fewer medications at 1 month, but not at 3 months. Further studies with longer follow up are needed to optimize the treatment parameters in order to maximize effectiveness while limiting side effects.</description><identifier>ISSN: 1435-604X</identifier><identifier>ISSN: 0268-8921</identifier><identifier>EISSN: 1435-604X</identifier><identifier>DOI: 10.1007/s10103-024-04086-z</identifier><identifier>PMID: 38795228</identifier><language>eng</language><publisher>London: Springer London</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Ciliary Body - surgery ; Cross-Sectional Studies ; Dentistry ; Effectiveness ; Energy ; Female ; Glaucoma ; Glaucoma - surgery ; Humans ; Intraocular pressure ; Intraocular Pressure - physiology ; Laser Coagulation - instrumentation ; Laser Coagulation - methods ; Lasers ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Optical Devices ; Optics ; Original Article ; Photonics ; Probes ; Quantum Optics ; Retrospective Studies ; Sclera - surgery ; Side effects ; Treatment Outcome</subject><ispartof>Lasers in medical science, 2024-05, Vol.39 (1), p.136-136, Article 136</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-bf41f58fb64b11bccf06dd882fb56c4740c8b9337016bd1c9369fc793889175e3</cites><orcidid>0000-0001-8646-0670</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38795228$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hadjokas, Nicholas</creatorcontrib><creatorcontrib>Dosakayala, Neelima</creatorcontrib><creatorcontrib>Alpert, Samuel</creatorcontrib><creatorcontrib>Ganapathy, Preethi</creatorcontrib><creatorcontrib>Fechtner, Robert</creatorcontrib><title>Settings and effectiveness of the revised probe compared to the original probe for micropulse transscleral cyclophotocoagulation</title><title>Lasers in medical science</title><addtitle>Lasers Med Sci</addtitle><addtitle>Lasers Med Sci</addtitle><description>Purpose The goal of this study was to compare the settings and effectiveness of the original P3 and revised P3 probes for micropulse transscleral cyclophotocoagulation. Methods This retrospective cross sectional study includes a total of 56 patients with glaucoma who received micropulse transscleral cyclophotocoagulation. 32 patients received treatment with the original P3 probe and 24 received treatment with the revised P3 probe. Success was defined as a 20% reduction in intraocular pressure. Laser settings, pre-op and post-op intraocular pressures, and pre-op and post-op medications were assessed. Results A 20% IOP reduction was achieved in 50% of patients in the original probe vs. 58.3% in the revised probe at one month ( P  = 0.536) and 71.9% vs. 50% at three months ( P  = 0.094), respectively. The revised P3 probe used higher values of power (2500 mW vs. 2023 mW, P  &lt; 0.0001), total duration (217 s vs. 179 s, P  &lt; 0.0001), and energy (170 J vs. 113 J, P  &lt; 0.001). There was a significant decrease in IOP lowering meds with the original probe at one month (-0.9 +/- 1.5 vs. -0.0 +/- 0.7, P  = 0.010), but this was not seen at three months. Conclusions There is no significant difference in IOP lowering effect between probes despite the revised probe using higher total energy. The original probe may be associated with fewer medications at 1 month, but not at 3 months. Further studies with longer follow up are needed to optimize the treatment parameters in order to maximize effectiveness while limiting side effects.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Ciliary Body - surgery</subject><subject>Cross-Sectional Studies</subject><subject>Dentistry</subject><subject>Effectiveness</subject><subject>Energy</subject><subject>Female</subject><subject>Glaucoma</subject><subject>Glaucoma - surgery</subject><subject>Humans</subject><subject>Intraocular pressure</subject><subject>Intraocular Pressure - physiology</subject><subject>Laser Coagulation - instrumentation</subject><subject>Laser Coagulation - methods</subject><subject>Lasers</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Optical Devices</subject><subject>Optics</subject><subject>Original Article</subject><subject>Photonics</subject><subject>Probes</subject><subject>Quantum Optics</subject><subject>Retrospective Studies</subject><subject>Sclera - surgery</subject><subject>Side effects</subject><subject>Treatment Outcome</subject><issn>1435-604X</issn><issn>0268-8921</issn><issn>1435-604X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1jAQhS0Eohd4ARbIEhs2gXGcOM4SVQUqVeoCKnVn2c74r6skDrZTqV3x6LjNz0UsuhqPzjdnPDqEvGHwgQF0HxMDBryCuqmgASmq-2fkkDW8rQQ0V8__eR-Qo5RuAFgnGH9JDrjs-rau5SH5-Q1z9vMuUT0PFJ1Dm_0tzpgSDY7ma6QRb33CgS4xGKQ2TIuOpc3hUQ3R7_ysx73sQqSTtzEs65iQ5qjnlOyIsRD2zo5huQ452KB366izD_Mr8sLpgr7e12Ny-fn0-8nX6vziy9nJp_PK1q3IlXENc610RjSGMWOtAzEMUtbOtMI2XQNWmp7zDpgwA7M9F72zXc-l7FnXIj8m7zff8s8fK6asJp8sjqOeMaxJcRDAu1pIKOi7_9CbsMZy40ZBWQYPVL1R5diUIjq1RD_peKcYqId81JaPKvmox3zUfRl6u7dezYTDn5HfgRSAb0Aq0rzD-Hf3E7a_ANfJnmk</recordid><startdate>20240525</startdate><enddate>20240525</enddate><creator>Hadjokas, Nicholas</creator><creator>Dosakayala, Neelima</creator><creator>Alpert, Samuel</creator><creator>Ganapathy, Preethi</creator><creator>Fechtner, Robert</creator><general>Springer London</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7SP</scope><scope>7U5</scope><scope>8FD</scope><scope>FR3</scope><scope>H8D</scope><scope>K9.</scope><scope>L7M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8646-0670</orcidid></search><sort><creationdate>20240525</creationdate><title>Settings and effectiveness of the revised probe compared to the original probe for micropulse transscleral cyclophotocoagulation</title><author>Hadjokas, Nicholas ; Dosakayala, Neelima ; Alpert, Samuel ; Ganapathy, Preethi ; Fechtner, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-bf41f58fb64b11bccf06dd882fb56c4740c8b9337016bd1c9369fc793889175e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Ciliary Body - surgery</topic><topic>Cross-Sectional Studies</topic><topic>Dentistry</topic><topic>Effectiveness</topic><topic>Energy</topic><topic>Female</topic><topic>Glaucoma</topic><topic>Glaucoma - surgery</topic><topic>Humans</topic><topic>Intraocular pressure</topic><topic>Intraocular Pressure - physiology</topic><topic>Laser Coagulation - instrumentation</topic><topic>Laser Coagulation - methods</topic><topic>Lasers</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Optical Devices</topic><topic>Optics</topic><topic>Original Article</topic><topic>Photonics</topic><topic>Probes</topic><topic>Quantum Optics</topic><topic>Retrospective Studies</topic><topic>Sclera - surgery</topic><topic>Side effects</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hadjokas, Nicholas</creatorcontrib><creatorcontrib>Dosakayala, Neelima</creatorcontrib><creatorcontrib>Alpert, Samuel</creatorcontrib><creatorcontrib>Ganapathy, Preethi</creatorcontrib><creatorcontrib>Fechtner, Robert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Lasers in medical science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hadjokas, Nicholas</au><au>Dosakayala, Neelima</au><au>Alpert, Samuel</au><au>Ganapathy, Preethi</au><au>Fechtner, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Settings and effectiveness of the revised probe compared to the original probe for micropulse transscleral cyclophotocoagulation</atitle><jtitle>Lasers in medical science</jtitle><stitle>Lasers Med Sci</stitle><addtitle>Lasers Med Sci</addtitle><date>2024-05-25</date><risdate>2024</risdate><volume>39</volume><issue>1</issue><spage>136</spage><epage>136</epage><pages>136-136</pages><artnum>136</artnum><issn>1435-604X</issn><issn>0268-8921</issn><eissn>1435-604X</eissn><abstract>Purpose The goal of this study was to compare the settings and effectiveness of the original P3 and revised P3 probes for micropulse transscleral cyclophotocoagulation. Methods This retrospective cross sectional study includes a total of 56 patients with glaucoma who received micropulse transscleral cyclophotocoagulation. 32 patients received treatment with the original P3 probe and 24 received treatment with the revised P3 probe. Success was defined as a 20% reduction in intraocular pressure. Laser settings, pre-op and post-op intraocular pressures, and pre-op and post-op medications were assessed. Results A 20% IOP reduction was achieved in 50% of patients in the original probe vs. 58.3% in the revised probe at one month ( P  = 0.536) and 71.9% vs. 50% at three months ( P  = 0.094), respectively. The revised P3 probe used higher values of power (2500 mW vs. 2023 mW, P  &lt; 0.0001), total duration (217 s vs. 179 s, P  &lt; 0.0001), and energy (170 J vs. 113 J, P  &lt; 0.001). There was a significant decrease in IOP lowering meds with the original probe at one month (-0.9 +/- 1.5 vs. -0.0 +/- 0.7, P  = 0.010), but this was not seen at three months. Conclusions There is no significant difference in IOP lowering effect between probes despite the revised probe using higher total energy. The original probe may be associated with fewer medications at 1 month, but not at 3 months. Further studies with longer follow up are needed to optimize the treatment parameters in order to maximize effectiveness while limiting side effects.</abstract><cop>London</cop><pub>Springer London</pub><pmid>38795228</pmid><doi>10.1007/s10103-024-04086-z</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-8646-0670</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1435-604X
ispartof Lasers in medical science, 2024-05, Vol.39 (1), p.136-136, Article 136
issn 1435-604X
0268-8921
1435-604X
language eng
recordid cdi_proquest_miscellaneous_3060372680
source Springer Link
subjects Adult
Aged
Aged, 80 and over
Ciliary Body - surgery
Cross-Sectional Studies
Dentistry
Effectiveness
Energy
Female
Glaucoma
Glaucoma - surgery
Humans
Intraocular pressure
Intraocular Pressure - physiology
Laser Coagulation - instrumentation
Laser Coagulation - methods
Lasers
Male
Medicine
Medicine & Public Health
Middle Aged
Optical Devices
Optics
Original Article
Photonics
Probes
Quantum Optics
Retrospective Studies
Sclera - surgery
Side effects
Treatment Outcome
title Settings and effectiveness of the revised probe compared to the original probe for micropulse transscleral cyclophotocoagulation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A47%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Settings%20and%20effectiveness%20of%20the%20revised%20probe%20compared%20to%20the%20original%20probe%20for%20micropulse%20transscleral%20cyclophotocoagulation&rft.jtitle=Lasers%20in%20medical%20science&rft.au=Hadjokas,%20Nicholas&rft.date=2024-05-25&rft.volume=39&rft.issue=1&rft.spage=136&rft.epage=136&rft.pages=136-136&rft.artnum=136&rft.issn=1435-604X&rft.eissn=1435-604X&rft_id=info:doi/10.1007/s10103-024-04086-z&rft_dat=%3Cproquest_cross%3E3060372680%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c256t-bf41f58fb64b11bccf06dd882fb56c4740c8b9337016bd1c9369fc793889175e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3060074000&rft_id=info:pmid/38795228&rfr_iscdi=true